关注
Karlo Toljan
Karlo Toljan
Cleveland Clinic
在 case.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Low-dose naltrexone (LDN)—review of therapeutic utilization
K Toljan, B Vrooman
Medical Sciences 6 (4), 82, 2018
1682018
Circadian rhythm and Alzheimer’s disease
J Homolak, M Mudrovčić, B Vukić, K Toljan
Medical sciences 6 (3), 52, 2018
1152018
Letter to the editor regarding the viewpoint “evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanism”
K Toljan
ACS chemical Neuroscience 11 (8), 1192-1194, 2020
902020
Sex hormone binding globulin (SHBG) as a marker of clinical disorders
K Toljan, F Grgić, D Pavičić Baldani, I Jurković, M Šprem Goldštajn
Collegium antropologicum 40 (3), 199-209, 2016
572016
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
K Toljan, M Amin, A Kunchok, D Ontaneda
Journal of Neuroimmunology 362, 577785, 2022
492022
Assessment of cardiovascular risk in transgender patients presenting for gender-affirming care
KJ Denby, L Cho, K Toljan, M Patil, CA Ferrando
The American Journal of Medicine 134 (8), 1002-1008, 2021
282021
Circadian changes in alzheimer's disease: neurobiology, clinical problems, and therapeutic opportunities
K Toljan, J Homolak
Handbook of Clinical Neurology 179, 285-300, 2021
102021
Psychoneuroimmunological approach to gastrointestinal related pain
K Toljan, B Vrooman
Scandinavian journal of pain 17 (1), 431-443, 2017
92017
Acute carotid stent thrombosis in an ultrarapid clopidogrel metabolizer: case report and literature review
K Toljan, I Jovanović, K Starčević, J Ljevak, N Blažević, M Radoš, ...
Vascular and Endovascular Surgery 53 (7), 602-605, 2019
72019
Therapeutic value of naltrexone as a glial modulator
D Agarwal, K Toljan, H Qureshi, B Vrooman
Arthritis Rheum 65 (2), 529-38, 2013
72013
Nanotechnology in stroke: new trails with smaller scales
K Toljan, A Ashok, V Labhasetwar, MS Hussain
Biomedicines 11 (3), 780, 2023
62023
Vladimir Sertić: forgotten pioneer of virology and bacteriophage therapy
Z Lacković, K Toljan
Notes and Records 74 (4), 567-578, 2020
62020
Another report of Hell’s itch due to sunburn
K Toljan
Journal of Travel Medicine 27 (7), taaa182, 2020
52020
Separating science from science fiction: A non-existent enzyme is a primary driver of pathophysiological processes in galactose-induced rodent models of aging
J Homolak, I Kodvanj, K Toljan, A Babic Perhoc, D Virag, ...
RG preprint 10, 2020
52020
Predictors for the development of neurological immune‐related adverse events of immune checkpoint inhibitors and impact on mortality
C Yan, M Huang, C Swetlik, K Toljan, AZ Mahadeen, J Bena, A Kunchok, ...
European Journal of Neurology 30 (10), 3221-3227, 2023
42023
Male sexual and reproductive health in multiple sclerosis: a scoping review
K Toljan, FBS Briggs
Journal of Neurology 271 (5), 2169-2181, 2024
12024
PRESENTING SYMPTOMS OF RELIGIOUS DELUSIONS AND HALLUCINATIONS IN TEMPORAL LOBE GLIOBLASTOMA
J Tiefenbach, K Toljan, E A Khawam, A C Viguera
Psychiatria Danubina 35 (3), 451-453, 2023
12023
Pearls & Oy-sters: Hemorrhagic Myelitis Following SARS-CoV-2 Infection
K Toljan, A Mahadeen, M Amin, M Rensel, SE Jones, D Ontaneda, ...
Neurology 101 (6), e672-e676, 2023
12023
Pediatric anti-NMDA-receptor autoimmune encephalitis in siblings: developmental, Electrophysiologic, and genetic implications
A Aboseif, K Toljan, A Mahadeen, A Zeft, AN Moosa, E Pestana-Knight, ...
Journal of Neuroimmunology 379, 578107, 2023
12023
Non-alcoholic components of Pelinkovac, a Croatian wormwood-based strong liquor, counteract the inhibitory effect of high ethanol concentration on catalase in vitro
J Homolak, AB Perhoc, M Joja, I Kodvanj, K Toljan, D Virag
BioRxiv, 2022.01. 07.475357, 2022
12022
系统目前无法执行此操作,请稍后再试。
文章 1–20